Draeger recalled 191,470 units of the ErgoStar CM 45 airway connector on November 10, 2025. Users reported cracks in the hose of specific catheter mounts, posing a high risk to patients. The recall affects healthcare facilities worldwide, including multiple U.S. states.
Multiple complaints were reported in which cracks formed in the hose of specific catheter mounts.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Draeger, Inc. or your healthcare provider for instructions. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
The recall includes the ErgoStar CM 45, Model/Catalog Number: MP01845. The product is used for conducting respiratory gases between the breathing system and the patient interface. It was distributed worldwide, including states such as California, Florida, and Texas.
Reports indicate that cracks formed in the hose of specific catheter mounts, which could compromise patient ventilation. This defect poses a significant risk for mechanically ventilated patients.
There are multiple complaints regarding the cracked hoses, but specific injury or incident counts have not been disclosed. No deaths have been reported.
Stop using the airway connector immediately. Follow the recall instructions provided by Draeger and contact your healthcare provider for further guidance.
For assistance, contact Draeger, Inc. at the number provided in your recall letter or visit their website for more details.
Get instant alerts for recalls that affect you. Free forever.
Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.
Fresenius Kabi Compounding recalled 1,057 bags of Acyclovir Sodium Injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers should cease use immediately and contact the manufacturer for guidance.
Fresenius Kabi Compounding recalled its vancomycin HCl injection on February 5, 2026, due to a lack of assurance of sterility. This Class II recall affects all lots distributed nationwide. Healthcare providers and consumers must stop using the product immediately.
Fresenius Kabi Compounding recalled 1,578 bags of vancomycin HCl injection on February 5, 2026. The company cited a lack of assurance of sterility as the reason for the recall. Healthcare providers and consumers should stop using the product immediately.
Fresenius Kabi Compounding recalled 1,410 bags of ketamine HCl injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers and consumers must stop using this product immediately.
Fresenius Kabi Compounding recalled 10,548 bags of thiamine HCl injection on February 5, 2026. The recall follows a lack of assurance of sterility, posing a high health risk. Affected products include several lots expiring between February and May 2026.
Pro Numb Tattoo Numbing Spray was recalled due to cGMP deviations. The recall affects products distributed nationwide in the USA. Consumers should stop using the spray immediately and contact Pro Numb Tattoo Numbing Spray LLC for guidance.
Pro Numb Tattoo Numbing Spray was recalled on February 2, 2026 due to cGMP deviations. The product, containing 4% lidocaine, is distributed by Pro Numb Tattoo Numbing Spray LLC. Consumers should stop using it immediately and contact the company for further guidance.